Cargando…
Evaluation of Novel 3-Hydroxyflavone Analogues as HDAC Inhibitors against Colorectal Cancer
Alteration of epigenetic enzymes is associated with the pathophysiology of colon cancer with an overexpression of histone deacetylase 8 (HDAC8) enzyme in this tissue. Numerous reports suggest that targeting HDAC8 is a viable strategy for developing new anticancer drugs. Flavonols provide a rich sour...
Autores principales: | Biswas, Subhankar, Reddy, Neetinkumar D., Jayashree, B. S., Rao, C. Mallikarjuna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327263/ https://www.ncbi.nlm.nih.gov/pubmed/30687400 http://dx.doi.org/10.1155/2018/4751806 |
Ejemplares similares
-
In vitro and in vivo anticancer studies of 2'-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest
por: Pande, Aditya Narayan, et al.
Publicado: (2017) -
Antidiabetic activity of 3-hydroxyflavone analogues in high fructose fed insulin resistant rats
por: Nayak, Yogendra, et al.
Publicado: (2014) -
Selected novel 5'-amino-2'-hydroxy-1, 3-diaryl-2-propen-1-ones arrest cell cycle of HCT-116 in G(0)/G(1 ) phase
por: Simon, Lalitha, et al.
Publicado: (2016) -
Synthesis and Characterization of New Pyrano[2,3-c]pyrazole Derivatives as 3-Hydroxyflavone Analogues
por: Urbonavičius, Arminas, et al.
Publicado: (2023) -
Differential roles of 3-Hydroxyflavone and 7-Hydroxyflavone against nicotine-induced oxidative stress in rat renal proximal tubule cells
por: Sengupta, Bidisha, et al.
Publicado: (2017)